163 related articles for article (PubMed ID: 37979033)
1. Explainability of random survival forests in predicting conversion risk from mild cognitive impairment to Alzheimer's disease.
Sarica A; Aracri F; Bianco MG; Arcuri F; Quattrone A; Quattrone A;
Brain Inform; 2023 Nov; 10(1):31. PubMed ID: 37979033
[TBL] [Abstract][Full Text] [Related]
2. Sex Differences in Conversion Risk from Mild Cognitive Impairment to Alzheimer's Disease: An Explainable Machine Learning Study with Random Survival Forests and SHAP.
Sarica A; Pelagi A; Aracri F; Arcuri F; Quattrone A; Quattrone A; For The Alzheimer's Disease Neuroimaging Initiative
Brain Sci; 2024 Feb; 14(3):. PubMed ID: 38539590
[TBL] [Abstract][Full Text] [Related]
3. XGBoost-SHAP-based interpretable diagnostic framework for alzheimer's disease.
Yi F; Yang H; Chen D; Qin Y; Han H; Cui J; Bai W; Ma Y; Zhang R; Yu H
BMC Med Inform Decis Mak; 2023 Jul; 23(1):137. PubMed ID: 37491248
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
5. NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease.
Garcia Condado J; Cortes JM;
Alzheimers Dement (Amst); 2023; 15(4):e12493. PubMed ID: 37908437
[TBL] [Abstract][Full Text] [Related]
6. Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment.
Chun MY; Park CJ; Kim J; Jeong JH; Jang H; Kim K; Seo SW
Front Aging Neurosci; 2022; 14():898940. PubMed ID: 35992586
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
Martínez-Florez JF; Osorio JD; Cediel JC; Rivas JC; Granados-Sánchez AM; López-Peláez J; Jaramillo T; Cardona JF
J Alzheimers Dis; 2021; 81(2):729-742. PubMed ID: 33814438
[TBL] [Abstract][Full Text] [Related]
8. Predicting Colorectal Cancer Survival Using Time-to-Event Machine Learning: Retrospective Cohort Study.
Yang X; Qiu H; Wang L; Wang X
J Med Internet Res; 2023 Oct; 25():e44417. PubMed ID: 37883174
[TBL] [Abstract][Full Text] [Related]
9. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
Beheshti I; Demirel H; Matsuda H;
Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
[TBL] [Abstract][Full Text] [Related]
10. Explainable Machine Learning with Pairwise Interactions for Predicting Conversion from Mild Cognitive Impairment to Alzheimer's Disease Utilizing Multi-Modalities Data.
Cai J; Hu W; Ma J; Si A; Chen S; Gong L; Zhang Y; Yan H; Chen F; For The Alzheimer's Disease Neuroimaging Initiative
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002495
[TBL] [Abstract][Full Text] [Related]
11. Short- and Long-Term Functional Connectivity Differences Associated with Alzheimer's Disease Progression.
Mondragón JD; Marapin R; De Deyn PP; Maurits N
Dement Geriatr Cogn Dis Extra; 2021; 11(3):235-249. PubMed ID: 34721501
[TBL] [Abstract][Full Text] [Related]
12. Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.
Wang M; Jiang J; Yan Z; Alberts I; Ge J; Zhang H; Zuo C; Yu J; Rominger A; Shi K;
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2753-2764. PubMed ID: 32318784
[TBL] [Abstract][Full Text] [Related]
13. Systematic comparison of 3D Deep learning and classical machine learning explanations for Alzheimer's Disease detection.
Bloch L; Friedrich CM;
Comput Biol Med; 2024 Mar; 170():108029. PubMed ID: 38308870
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
[TBL] [Abstract][Full Text] [Related]
15. Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
Kishore N; Goel N
Neurosci Lett; 2023 Nov; 817():137530. PubMed ID: 37858874
[TBL] [Abstract][Full Text] [Related]
16. Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.
Yang Y; Ma X; Wang Y; Ding X
Updates Surg; 2022 Feb; 74(1):355-365. PubMed ID: 34003477
[TBL] [Abstract][Full Text] [Related]
17. A review on Alzheimer's disease classification from normal controls and mild cognitive impairment using structural MR images.
Garg N; Choudhry MS; Bodade RM
J Neurosci Methods; 2023 Jan; 384():109745. PubMed ID: 36395961
[TBL] [Abstract][Full Text] [Related]
18. A Classification Algorithm by Combination of Feature Decomposition and Kernel Discriminant Analysis (KDA) for Automatic MR Brain Image Classification and AD Diagnosis.
Elahifasaee F; Li F; Yang M
Comput Math Methods Med; 2019; 2019():1437123. PubMed ID: 32082407
[TBL] [Abstract][Full Text] [Related]
19. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
20. Discriminating Alzheimer's disease progression using a new hippocampal marker from T1-weighted MRI: The local surface roughness.
Platero C; López ME; Carmen Tobar MD; Yus M; Maestu F
Hum Brain Mapp; 2019 Apr; 40(5):1666-1676. PubMed ID: 30451343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
